Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001377 · ClinicalTrials.gov registry record
Familial Prostate Cancer
A clinical trial, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 200
- Enrollment target
NCT00001377: Completed study, sponsored by National Cancer Institute (NCI).
NCT00001377 is a clinical trial that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 200 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001377 has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 200 participants
- Enrollment target
Study Summary
The purpose of this study is to identify affected individuals in families with prostate cancer and to use this information to identify genetic markers closely-linked to the disease gene.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 1993-12 |
| Est. Completion | 2000-12 |
What the finished NCT00001377 record still lists
NCT00001377 is an observational study that tracks outcomes without assigning an intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT00001377 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001377 about?
NCT00001377 is a clinical study titled "Familial Prostate Cancer". The purpose of this study is to identify affected individuals in families with prostate cancer and to use this information to identify genetic markers closely-linked to the disease gene.
What is the current status of trial NCT00001377?
This trial is currently completed. The enrollment target is 200 participants. The study started on 1993-12. Estimated completion is 2000-12.
Who is sponsoring clinical trial NCT00001377?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia